
We are using the gut microbiome to end cancer.
Persephone Biosciences is headquartered in San Diego, CA.
We are using the gut microbiome to end cancer.
Their own 'My Baby Biome' study found 9 out of 10 U.S. babies are born without essential gut bacteria, raising risk of food sensitivities/eczema, asthma/allergies, weakened immunity, and chronic inflammation.
Makes a synbiotic supplement for infants and toddlers that pairs keystone probiotic strains (Bifidobacterium) with an HMO prebiotic blend modeled on breast milk to replenish missing gut bacteria.
Backed by a randomized, double-blind, placebo-controlled clinical trial (ARTEMIS) published in Pediatric Research, a Nature Portfolio journal, plus Clean Label Project certification and third-party/deep DNA-sequenced batch testing.
Co-founded in 2017 by Dr. Stephanie Culler and Dr. Steve Van Dien; the San Diego biotech closed a $15M seed round in 2022 to develop gut-microbiome-based cancer immunotherapies.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.